Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (s)-(-)-nadifloxacin
1. 154357-42-3
2. (s)-(-)-nadifloxacin
3. 8whh66l098
4. Wck771 Free Base
5. Nadifloxacin, (s)-
6. Wck-771 Free Base
7. Dtxsid70165599
8. Levonadifloxacine
9. Levonadifloxacino
10. Levonadifloxacinum
11. Refchem:924705
12. Dtxcid0088090
13. (5s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid
14. Levonadifloxacin [inn]
15. (s)-nadifloxacin
16. Wck771
17. (12s)-7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid
18. 1h,5h-benzo[ij]quinolizine-2-carboxylicacid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5s)-
19. Chebi:37908
20. Mfcd09954130
21. (s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic Acid
22. Levonadifloxacin (inn)
23. (5s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic Acid
24. C19h21fn2o4
25. Unii-8whh66l098
26. Starbld0002875
27. Schembl36594
28. Chembl190561
29. Schembl29390463
30. Gtpl10757
31. Levonadifloxacin [who-dd]
32. Glxc-27365
33. Bdbm50475221
34. (s)-9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1h,5h-benzo[i,j]quinolizine-2-carboxylic Acid
35. Da-48828
36. Hy-14926
37. Ms-25695
38. Sy343606
39. Cs-0003639
40. Ns00098910
41. D11933
42. F82021
43. Q27117310
44. (12s)-7-fluoro-8-(4-hydroxy-1-piperidyl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid
45. (5s)-9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid
46. (5s)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinolizine-2-carboxylic Acid
47. (s)-(-)-nadifloxacin; 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5s)-; 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (s)-; (5s)-9-fluoro-6,7-
48. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5s)-
49. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (s)-
Molecular Weight | 360.4 g/mol |
---|---|
Molecular Formula | C19H21FN2O4 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 2 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 81.1 |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 631 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
beta-Lactamase Inhibitors
Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01M - Quinolone antibacterials
J01MA - Fluoroquinolones
J01MA24 - Levonadifloxacin
ABOUT THIS PAGE